Centre for Behavioural Research in Cancer, Cancer Council Victora, Melbourne, Australia.
Quit Victoria, Cancer Council Victoria, Melbourne, Australia.
Public Health Res Pract. 2024 Jun 19;34(2):34122405. doi: 10.17061/phrp34122405.
On 2 May 2023, the Australian Federal Government announced a suite of reforms aimed at ensuring the effectiveness of the prescription model of regulation of vaping (or e-cigarette) products in Australia. These reforms are intended to protect Australians, particularly young people, from the harms of vaping and nicotine dependence. The ensuing public debate on the issue has often created the impression that the options under consideration are to either retain 'recently introduced' prescription regulation or to 'revert to' a retail supply approach. However, the sale of nicotine vapes by retailers such as tobacconists and convenience stores has never been lawful in Australia. The reforms do not seek to change the way nicotine vaping products are regulated, but rather to ensure that the existing prescription model can be effectively enforced and can function as originally intended. This paper describes the historical context and rationale for strengthening prescription regulation of vapes in this country.
2023 年 5 月 2 日，澳大利亚联邦政府宣布了一系列改革措施，旨在确保澳大利亚对电子烟（或电子香烟）产品的处方监管模式的有效性。这些改革旨在保护澳大利亚人，特别是年轻人，免受电子烟和尼古丁依赖的危害。由此引发的关于这个问题的公众辩论经常给人留下这样的印象，即正在考虑的选择要么是保留“最近引入的”处方监管，要么是“恢复”零售供应方法。然而，在澳大利亚，零售商（如烟草店和便利店）销售尼古丁电子烟从未合法过。这些改革并不是要改变尼古丁电子烟产品的监管方式，而是要确保现有的处方模式能够得到有效执行，并能按最初的设想发挥作用。本文描述了在本国加强电子烟处方监管的历史背景和基本原理。
